Abordaje integral del cáncer gástrico avanzado - page 40

RAINBOW

RAMUCIRUMAB +

PACLITAXEL

330 p

SVG 9.6 m

SV 6 m: 72 %

SV 12 m: 40 %

SLP 4.4 m

RP 27 %

EE 52 %

PLACEBO +

PACLITAXEL

335 p

SVG 7.4 m

SV 6 m: 57 %

SV 12 m: 30%

SLP 2.9 m

RP 16 %

EE 47 %

HR 0.807, p 0.017

HR 0.635, p 0.0001

HR 0.807, p < 0.01

OBJETIVO 1º

> 18 a

ECOG 0 – 1

Irresecable o MTS

Previo Platino-Fp +/-

Progresión < 4 m

1:1

Wilke H, et al. Lancet Oncol 2014

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,30,31,32,33,34,35,36,37,38,39 41,42,43,44,45,46,47,48,49,50,...65